हिंदी में पढ़ें

Cipla

Cipla's Reaction to USFDA's Actions on 8th November, WATCH details here

Cipla's Reaction to USFDA's Actions on 8th November, WATCH details here

Fri, Nov 24, 2023

Cipla's clarification on USFDA's action, warning letter was received on 8th November, investigation was conducted on 6-17th February, Cipla's share fell by almost 8% yesterday, know the complete details in this video.

Cipla's Promoter Shareholding Faces Possible Revamp with Key Changes

Cipla's Promoter Shareholding Faces Possible Revamp with Key Changes

Mon, Nov 13, 2023

Big news related to Cipla Big changes in promoter shareholding possible, may come in passive role #Cipla's promoter management may get big responsibility, Samina Hameed may come in non-executive role, know complete details in this video

Big Update On Cipla Pharma: Bids to buy promoters' shares soon-sources

Big Update On Cipla Pharma: Bids to buy promoters' shares soon-sources

Thu, Sep 14, 2023

Cipla से जुड़ी Big news related to Cipla: Bids to buy promoters' shares will start soon, bids to buy shares possible by the third week of this month.

TRENDING NOW

Cipla acquires 4 nutrition brands from Wanbury

Cipla acquires 4 nutrition brands from Wanbury

Sat, Feb 08, 2020

Cipla — a homegrown pharma firm — on Saturday announced the acquisition of a nutrition product portfolio from Wanbury Ltd.

Stock Market: Sensex, Nifty trade range-bound on weak global cues; Cipla, ITI, RBL Bank stocks crash

Stock Market: Sensex, Nifty trade range-bound on weak global cues; Cipla, ITI, RBL Bank stocks crash

Thu, Jan 23, 2020

BSE Sensex added 50 points and scaled at 41,165 levels while the 50-stocks Nifty nudged 6 points higher at 12,112 levels. Bank Nifty index went up 95 points at 30,796 levels.

Stocks in Focus on January 23: ITI, Cipla to Telecom shares; here are expected 5 Newsmakers of the Day

Stocks in Focus on January 23: ITI, Cipla to Telecom shares; here are expected 5 Newsmakers of the Day

Thu, Jan 23, 2020

Cipla, ITI, CPSE ETF, GHCL and telecom stocks are expected to remain newsmakers throughout the intraday trade session.

Stocks in Focus on December 17: Cipla, Equitas Holdings, NIIT Tech; here are the 5 Newsmakers of the Day

Stocks in Focus on December 17: Cipla, Equitas Holdings, NIIT Tech; here are the 5 Newsmakers of the Day

Tue, Dec 17, 2019

Cipla, Equitas Holdings, Raymond, NIIT Technologies and Apollo Hospital are the stocks that are expected to remain newsmakers throughout the intraday trade session.

Execution of Multiple Therapies led to robust growth in Q2: Kedar Upadhye, Global CFO, Cipla Limited

Execution of Multiple Therapies led to robust growth in Q2: Kedar Upadhye, Global CFO, Cipla Limited

Mon, Nov 11, 2019

Kedar Upadhye, Global Chief Financial Officer, Cipla Limited, talks about September quarter results, expectations for next two quarters and USFDA observation in Goa plant among others during an interview with Mansee Dave, Zee Business. Edited Excerpts:

Stocks in Focus on September 30: IRCTC, DHFL to RNAM; here are the 5 Newsmakers of the Day

Stocks in Focus on September 30: IRCTC, DHFL to RNAM; here are the 5 Newsmakers of the Day

Mon, Sep 30, 2019

IRCTC, Lakshmi Vilas bank/Indiabulls Housing Finance, DHFL, Cipla and Reliance Nippon Life AMC/Reliance Capital are the stocks that are expected to remain in focus on September 30.

Cipla is investing a lot on R&D; Clinical trial of Generic Advair’s is going on track: Kedar Upadhye

Cipla is investing a lot on R&D; Clinical trial of Generic Advair’s is going on track: Kedar Upadhye

Tue, Aug 13, 2019

Cipla has launched several limited component products in the last 3-4 quarters, especially in quarter 4 and quarter 1.

Stocks in Focus on July 22: Bosch, Dr Reddy’s to BHEL; here are the 5 Newsmakers of the Day

Stocks in Focus on July 22: Bosch, Dr Reddy’s to BHEL; here are the 5 Newsmakers of the Day

Mon, Jul 22, 2019

Certain stocks came in news after the market was closed for the day. These stocks can have an impact on the indices after the market is opened for trading purposes on Monday, July 22, 2019.

Cipla gets EIR from USFDA for Kurkumbh facility

Cipla gets EIR from USFDA for Kurkumbh facility

Mon, Jun 10, 2019

The Kurkumbh manufacturing facility was inspected by the United States Food and Drug Administration (USFDA) from March 11 to March 20, 2019, Cipla said in a BSE filing.

'10 ki Kamai': Should you buy Cipla shares? Expert gives this target

'10 ki Kamai': Should you buy Cipla shares? Expert gives this target

Mon, May 27, 2019

Sumeet Bagadia, ED, Choice Broking told Zee Business TV, ''Cipla is looking positive for last few months. The stock has broken the 200 DMA levels and seems a decent buy for short term targets of Rs 600 and Rs 610.

Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr

Cipla Q4 net profit jumps over 2-fold to Rs 357.68 cr; to raise up to Rs 6,000 cr

Wed, May 22, 2019

For the 2018-19 fiscal, the company's net profit was Rs 1,492.44 crore as against Rs 1,416.57 crore in 2017-18. Total revenue from operations for the last fiscal stood at Rs 16,362.41 crore. It was Rs 15,219.25 crore in the preceding financial year.

Cipla to launch cinacalcet hydrochloride tablets in US.

Cipla to launch cinacalcet hydrochloride tablets in US.

Wed, Mar 06, 2019

Cipla said, its cinacalcet hydrochloride tablets in the strengths of 30mg, 60mg and 90mg) is generic therapeutic equivalent version of Sensipar, a branded drug marketed by Amgen Inc.

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018

Mon, Dec 31, 2018

The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.

Cipla recalls 4,800 bottles of anti-HIV tablets from US

Cipla recalls 4,800 bottles of anti-HIV tablets from US

Sun, Dec 30, 2018

As per the latest Enforcement Report by the United States Food and Drug Administration (USFDA), the reason for the recall of the bottles is 'failed dissolution specifications'.

Top 5 stocks in focus on July 12: HCL, Telecom sector to Cipla, here are the 5 newsmakers of the day

Top 5 stocks in focus on July 12: HCL, Telecom sector to Cipla, here are the 5 newsmakers of the day

Thu, Jul 12, 2018

The domestic market remained flat on July 11, 2018, as the BSE Sensex and Nifty closed in green while BankNifty depreciated by 78.35 points. But there were certain stocks that made news on the day and can have an impact on the market on July 12, 2018.

Cipla share price rallies 3% on USFDA nod to generic HIV drug

Cipla share price rallies 3% on USFDA nod to generic HIV drug

Wed, Jun 20, 2018

Cipla share price rallied over 3 per cent after the drug major received approval from the US health regulator to market Efavirenz tablets. These tablets are used to treat HIV-1 infections in adults. Reacting to the news, the stock gained as much as 3.27 per cent to Rs 622 on the BSE.

Infosys, Cipla among key stocks hogging limelight in Wednesday's trade

Infosys, Cipla among key stocks hogging limelight in Wednesday's trade

Wed, Jun 20, 2018

Overnight, US stocks fell on Tuesday as a sharp escalation in the trade dispute between the United States and China rattled markets and put the Dow Jones Industrial Average back in negative territory for the year. However, S&P 500 futures edged slightly higher, rising 0.05 per cent.

Cipla share price surges 7% on robust Q4 earnings

Cipla share price surges 7% on robust Q4 earnings

Wed, May 23, 2018

Reacting to positive earnings, the stock gained as much as 6.78 per cent to Rs 562.50 on the BSE. The scrip settled at Rs 532.75, up 1.6 per cent.

Sensex surges over 500 points; key reasons behind smart pullback today

Sensex surges over 500 points; key reasons behind smart pullback today

Thu, Feb 08, 2018

The S&P BSE Sensex rallied over 500 points intraday, snapping the seven-session long losing streak, while the broader Nifty50 also regained its crucial 10,600 mark. The Sensex, however, is still over 1800 points down from its peak 36443.98 hit on January 29, 2018.

Sensex at day's high; Cipla, PVR among key stocks buzzing today

Sensex at day's high; Cipla, PVR among key stocks buzzing today

Thu, Feb 08, 2018

The domestic market snapped its seven-session long losing streak on Thursday with the Nifty regaining its crucial 10,600 mark on the back of value-buying and as market heavyweights such as Infosys recovered and as drug maker Cipla gained on solid earnings.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x